Atara Biotherapeutics, Inc. (LON:0HIY)
London flag London · Delayed Price · Currency is GBP · Price in USD
9.49
+0.08 (0.85%)
At close: Jul 11, 2025

Atara Biotherapeutics Statistics

Total Valuation

LON:0HIY has a market cap or net worth of GBP 40.76 million. The enterprise value is 61.58 million.

Market Cap 40.76M
Enterprise Value 61.58M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 5.96M
Shares Outstanding n/a
Shares Change (YoY) +90.64%
Shares Change (QoQ) +1.32%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 3.44M

Valuation Ratios

PE Ratio n/a
Forward PE 2.84
PS Ratio 0.26
PB Ratio -0.96
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.42, with an EV/FCF ratio of -1.18.

EV / Earnings -5.09
EV / Sales 0.42
EV / EBITDA 4.42
EV / EBIT n/a
EV / FCF -1.18

Financial Position

The company has a current ratio of 0.57

Current Ratio 0.57
Quick Ratio 0.47
Debt / Equity n/a
Debt / EBITDA 2.23
Debt / FCF -0.62
Interest Coverage -0.72

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -1.77%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -22.76%
Revenue Per Employee 1.74M
Profits Per Employee -136,022
Employee Count 153
Asset Turnover 1.76
Inventory Turnover n/a

Taxes

Income Tax -27,864
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +11.16% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +11.16%
50-Day Moving Average 7.95
200-Day Moving Average 8.85
Relative Strength Index (RSI) 66.77
Average Volume (20 Days) 234

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.93

Income Statement

In the last 12 months, LON:0HIY had revenue of GBP 154.59 million and -12.11 million in losses. Loss per share was -1.38.

Revenue 154.59M
Gross Profit 27.53M
Operating Income -2.49M
Pretax Income -12.13M
Net Income -12.11M
EBITDA 1.73M
EBIT -2.49M
Loss Per Share -1.38
Full Income Statement

Balance Sheet

The company has 10.71 million in cash and 32.46 million in debt, giving a net cash position of -21.75 million.

Cash & Cash Equivalents 10.71M
Total Debt 32.46M
Net Cash -21.75M
Net Cash Per Share n/a
Equity (Book Value) -42.63M
Book Value Per Share -7.20
Working Capital -16.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -52.05 million and capital expenditures -92,105, giving a free cash flow of -52.14 million.

Operating Cash Flow -52.05M
Capital Expenditures -92,105
Free Cash Flow -52.14M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 17.81%, with operating and profit margins of -1.61% and -7.83%.

Gross Margin 17.81%
Operating Margin -1.61%
Pretax Margin -7.85%
Profit Margin -7.83%
EBITDA Margin 1.12%
EBIT Margin -1.61%
FCF Margin n/a

Dividends & Yields

LON:0HIY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -90.64%
Shareholder Yield n/a
Earnings Yield -29.70%
FCF Yield -127.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date Jun 20, 2024
Split Type Reverse
Split Ratio 0.04

Scores

LON:0HIY has an Altman Z-Score of -42.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -42.57
Piotroski F-Score 2